JP2012507308A5 - - Google Patents

Download PDF

Info

Publication number
JP2012507308A5
JP2012507308A5 JP2011535539A JP2011535539A JP2012507308A5 JP 2012507308 A5 JP2012507308 A5 JP 2012507308A5 JP 2011535539 A JP2011535539 A JP 2011535539A JP 2011535539 A JP2011535539 A JP 2011535539A JP 2012507308 A5 JP2012507308 A5 JP 2012507308A5
Authority
JP
Japan
Prior art keywords
seq
oligonucleotide
oligonucleotide according
isolated
pharmaceutical composition
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2011535539A
Other languages
English (en)
Japanese (ja)
Other versions
JP5746038B2 (ja
JP2012507308A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/SE2009/051247 external-priority patent/WO2010053435A2/en
Publication of JP2012507308A publication Critical patent/JP2012507308A/ja
Publication of JP2012507308A5 publication Critical patent/JP2012507308A5/ja
Application granted granted Critical
Publication of JP5746038B2 publication Critical patent/JP5746038B2/ja
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2011535539A 2008-11-04 2009-11-04 Ｃｎｓの炎症性疾患の治療のための化合物および方法 Expired - Fee Related JP5746038B2 (ja)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US11128708P 2008-11-04 2008-11-04
US61/111,287 2008-11-04
SE0802339 2008-11-04
SE0802339-2 2008-11-04
PCT/SE2009/051247 WO2010053435A2 (en) 2008-11-04 2009-11-04 Compounds and methods for the treatment of inflammatory diseases of the cns

Publications (3)

Publication Number Publication Date
JP2012507308A JP2012507308A (ja) 2012-03-29
JP2012507308A5 true JP2012507308A5 (enExample) 2012-12-06
JP5746038B2 JP5746038B2 (ja) 2015-07-08

Family

ID=42153438

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2011535539A Expired - Fee Related JP5746038B2 (ja) 2008-11-04 2009-11-04 Ｃｎｓの炎症性疾患の治療のための化合物および方法

Country Status (8)

Country Link
US (3) US8637479B2 (enExample)
EP (1) EP2350283B1 (enExample)
JP (1) JP5746038B2 (enExample)
AU (1) AU2009311753B2 (enExample)
CA (1) CA2778961C (enExample)
DK (1) DK2350283T3 (enExample)
ES (1) ES2560782T3 (enExample)
WO (1) WO2010053435A2 (enExample)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2464731T3 (es) 2008-11-04 2014-06-03 Index Pharmaceuticals Ab Compuestos y procedimientos para reducir el reclutamiento y/o migración de células polimorfonucleares
EP2468866A1 (en) * 2010-12-21 2012-06-27 Index Pharmaceuticals AB Biologically active oligonucleotides capable of modulating the immune system
WO2012084991A1 (en) * 2010-12-21 2012-06-28 Index Pharmaceuticals Ab Biologically active oligonucleotides capable of modulating the immune system ii
EP2596806A1 (en) 2011-11-25 2013-05-29 Index Pharmaceuticals AB Method for prevention of colectomy
US11672757B2 (en) * 2017-06-28 2023-06-13 University Of Pittsburgh-Of The Commonwealth System Of Higher Education Hot melt extrusion for pharmaceutical vaginal film products

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AR040996A1 (es) * 2002-08-19 2005-04-27 Coley Pharm Group Inc Acidos nucleicos inmunoestimuladores
AU2004255470B2 (en) * 2003-07-10 2010-08-19 Cytos Biotechnology Ag Packaged virus-like particles
EP1819364A4 (en) * 2004-12-08 2010-12-29 3M Innovative Properties Co COMPOSITIONS, IMMUNOMODULATORY COMBINATIONS AND ASSOCIATED METHODS
WO2006065751A2 (en) 2004-12-13 2006-06-22 Government Of The United States Of America, Represented By The Secretary, Department Of Health And Human Services Cpg oligonucleotide prodrugs, compositions thereof and associated therapeutic methods
SI2380584T1 (sl) * 2005-07-01 2014-04-30 Index Pharmaceuticals Ab Imunostimulatorni postopek
PT2179737E (pt) * 2005-07-01 2013-12-05 Index Pharmaceuticals Ab Método para modular a capacidade de resposta aos esteróides
WO2007030581A2 (en) * 2005-09-09 2007-03-15 Oregon Health & Science University Neuroprotectants
AU2006306805A1 (en) 2005-10-28 2007-05-03 Index Pharmaceuticals Ab Composition and method for the prevention, treatment and/or alleviation of an inflammatory disease
WO2007095316A2 (en) 2006-02-15 2007-08-23 Coley Pharmaceutical Gmbh Compositions and methods for oligonucleotide formulations
EP1894941A1 (en) * 2006-09-01 2008-03-05 Institut Pasteur Treatment of cervical carcinoma with a recombinant adenylate cyclase carrying HPV antigens
US8309529B2 (en) * 2007-05-04 2012-11-13 Index Pharmaceuticals Ab Tumour growth inhibitory compounds and methods of their use
EP2155889A4 (en) * 2007-05-25 2010-06-16 Centocor Ortho Biotech Inc TOLL RECEPTOR 3 MODULATORS AND USES THEREOF
EP2207555B1 (en) 2007-10-05 2013-07-24 InDex Pharmaceuticals AB Oligonucleotides for the treatment or alleviation of edema
US20110182880A1 (en) 2008-06-18 2011-07-28 Oliver Von Stein Combination Therapies Against Cancer
ES2464731T3 (es) * 2008-11-04 2014-06-03 Index Pharmaceuticals Ab Compuestos y procedimientos para reducir el reclutamiento y/o migración de células polimorfonucleares

Similar Documents

Publication Publication Date Title
Yang et al. A systematic review of the research progress of non-coding RNA in neuroinflammation and immune regulation in cerebral infarction/ischemia-reperfusion injury
TWI721128B (zh) 用於降低pd-l1表現之寡核苷酸
Liang et al. Circulating microRNAs as emerging regulators of COVID-19
JP2013504542A5 (enExample)
US8492357B2 (en) Micro-RNA mediated modulation of colony stimulating factors
Zhang et al. LncRNA MEG8 regulates vascular smooth muscle cell proliferation, migration and apoptosis by targeting PPARα
ES2749855T3 (es) Procedimientos y composiciones para la inhibición específica de glicolato oxidasa (hao1) por ARN bicatenario
KR101589442B1 (ko) 에스디에프-1 결합형 핵산 및 이의 용도
ES2873893T3 (es) Métodos y composiciones para la inhibición específica de beta-catenina por RNA bicatenario
Chlamydas et al. Epigenetic mechanisms regulate sex-specific bias in disease manifestations
CN102099474B (zh) 用于治疗炎症和赘生性细胞增殖的寡核苷酸
JP2011500858A5 (enExample)
CN119343142A (zh) 治疗具有与血细胞分化相关的临床显著体征和症状的受试者的方法
EA034924B1 (ru) Олигомеры и олигомерные конъюгаты
WO2010151755A2 (en) TREATMENT OF INFLAMMATORY DISEASES USING miR-124
CN103298475A (zh) 作为治疗剂的寡核苷酸类似物的设计
KR20150119924A (ko) 백신 애쥬번트 및 치료제로서의 짧은 올리고뉴클레오티드의 설계
Shan et al. Immunomodulation: The next target of mesenchymal stem cell-derived exosomes in the context of ischemic stroke
AU2023254203A1 (en) Lipid nanoparticles for gene editing systems
Jia et al. Retracted article: MicroRNA-210 protects against periodontitis through targeting HIF-3α and inhibiting p38MAPK/NF-κB pathway
CN104004762B (zh) Tgf-r反义序列及其在制备抗气道炎症反应药物中的应用
CN104278030A (zh) 小分子化合物Antagomir-31制备方法及应用
JP2020513849A5 (enExample)
EP2814498B1 (en) Guanosine-rich oligonucleotide (gro) compositions and uses for treating respiratory syncytial virus infection
WO2009040819A3 (en) DOWN-REGULATION OF MORTALIN BY siRNA